Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Aug 10, 2016 $29.73 $30.50 $27.23 $29.04 463 000
Aug 09, 2016 $29.96 $30.39 $29.25 $29.70 726 800
Aug 08, 2016 $30.00 $30.68 $29.53 $30.04 1 108 300
Aug 05, 2016 $28.18 $29.57 $27.94 $29.12 373 000
Aug 04, 2016 $27.92 $28.35 $27.31 $28.09 226 300
Aug 03, 2016 $27.06 $28.26 $26.88 $27.92 314 000
Aug 02, 2016 $25.78 $27.49 $25.59 $27.33 498 900
Aug 01, 2016 $25.67 $25.97 $25.20 $25.82 174 400
Jul 29, 2016 $24.44 $25.57 $24.42 $25.39 240 300
Jul 28, 2016 $26.15 $26.27 $24.42 $24.57 260 200
Jul 27, 2016 $25.23 $26.22 $25.15 $25.78 245 900
Jul 26, 2016 $24.06 $24.85 $24.00 $24.70 177 500
Jul 25, 2016 $24.25 $24.44 $23.80 $24.12 119 500
Jul 22, 2016 $24.19 $24.33 $23.16 $24.22 330 800
Jul 21, 2016 $26.23 $26.61 $23.53 $23.98 363 700
Jul 20, 2016 $24.07 $26.13 $23.41 $26.10 542 700
Jul 19, 2016 $23.43 $24.15 $23.07 $23.85 344 800
Jul 18, 2016 $23.70 $23.90 $22.02 $23.44 222 300
Jul 15, 2016 $22.33 $23.95 $21.95 $23.61 437 900
Jul 14, 2016 $22.81 $22.81 $21.21 $22.12 324 900
Jul 13, 2016 $23.00 $23.13 $22.08 $22.60 550 600
Jul 12, 2016 $20.98 $22.98 $20.94 $22.91 677 700
Jul 11, 2016 $17.88 $22.00 $17.65 $21.93 1 861 200
Jul 08, 2016 $16.50 $17.29 $16.11 $17.22 487 700
Jul 07, 2016 $16.67 $16.85 $16.29 $16.43 332 200
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT